急性ST段上抬型心肌梗死合并1型心肾综合征的危险因素  

Risk factors for Type 1 cardio-renal syndrome after ST-segment elevation myocardial infarction

作　　者：潘宏伟[1] 郭莹[1] 郑昭芬[1] 彭建强[1] 张宇[1] 何晋[1] 刘征宇[1] 胡勇军[1] 王长录[1] 

机构地区：[1]湖南省人民医院心内科,长沙410005

出　　处：《中南大学学报（医学版）》2014年第4期355-360,共6页Journal of Central South University ：Medical Science

摘　　要：目的:探讨急性ST段上抬型心肌梗死(ST-segment elevation myocardial infarction,STEMI)患者发生1型心肾综合征(cardio-renal syndrome Type 1,CRS1)的危险因素。方法:STEMI患者378例分为CRS1组(n=98)和非CRS1组(n=280)。比较两组患者的临床资料,分析STEMI患者发生CRS1的独立危险因素,观察急诊冠脉介入治疗(percutaneous coronary intervention,PCI)对STEMI患者发生CRS1的影响。结果:378例STEMI患者中发生CRS1共98例(25.9%),两组间年龄、糖尿病史、入院平均动脉压、入院收缩压、入院心率、Killip分级、左室射血分数、血清肌酐基值、基础预估肾小球滤过率(evaluated glomerular filtration rate,eGFR)、急诊PCI、β-受体阻滞剂和血管紧张素转化酶抑制剂/血管紧张素II受体拮抗剂(angiotensin converting enzyme inhibitors/angiotensin II receptor antagonist,ACEI/ARB)应用在内的十二项指标差异具有统计学意义(均P<0.05),多因素logistic分析显示年龄、糖尿病史、入院收缩压降低、心功能Killip分级、左室射血分数降低、基础eGFR降低、未急诊PCI、未使用ACEI/ARB药物是STEMI患者发生CRS1的独立危险因素。256例患者接受急诊PCI,50例(19.5%)出现CRS1。CRS1组门-球时间及对比剂用量明显高于无CRS1患者(均P<0.05),但术后"罪犯血管"血流恢复情况两组间比较差异无统计学意义(P>0.05)。结论:CRS1是STEMI常见的并发症,其发生与多种因素有关,及时的血运重建能降低STEMI患者的CRS1发生率。Objective: To explore the risk factors for Type 1 cardio-renal syndrome (CRS1) atfer ST-segment elevation myocardial infarction (STEMI). Methods: A total of 378 patients with STEMI were divided into two groups: a CRS1 group (n=98) and a non-CRS1 group (n=280). Clinical characteristics in the 2 groups were compared, and independent risk factors for CRS1 after STEMI were analyzed, and the effect of emergency Results: In the 378 STEMI patients, CRS1 was found in 98 patients (25.9%). Between the 2 groups, there was significant difference in 12 parameters, including age, history of diabetes, admission mean arterial pressure, admission systolic blood pressure, admission heart rate, Killip classification, left ventricular ejection fraction, baseline serum creatinine, baseline evaluated glomerular ifltration rate (eGFR), emergency PCI, β-blockers and angiotensin converting enzyme inhibitor/angiotensin, receptor antagonist (ACEI/ARB) application (allP<0.05). Multivariate logistic regression showed that age, history of diabetes, admission systolic blood pressure, Killip classification, reduced left ventricular ejection fraction, reduced eGFR, emergency PCI non-undergo and ACEI/ARB non-use were independent risk factors for CRS1 atfer STEMI. In the 256 patients undergoing emergency PCI, 50 patients (19.5%) had CRS1. hTe door-ball time and the amount of contrast agent in the CRS1 group were signiifcantly higher than those in the non- CRS1 group (bothP<0.05), but there was no signiifcant difference in the blood lfow in the “culprit vessel”atfer the PCI (P>0.05). Conclusion: CRS1 is a common complication of STEMI, which is associated with many factors. Immediate revascularization can reduce the incidence of CRS1 in patients with ST-segment elevation myocardial infarction.

关 键 词：急性ST段上抬型心肌梗死 1型心肾综合征 经皮冠脉介入治疗 

分 类 号：R542.22[医药卫生—心血管疾病]